Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723596 | SCV000113949 | uncertain significance | not provided | 2013-06-18 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000723596 | SCV000615145 | uncertain significance | not provided | 2019-12-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000542565 | SCV000634407 | benign | Eichsfeld type congenital muscular dystrophy | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723596 | SCV000729489 | likely benign | not provided | 2021-04-02 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20623375) |
Illumina Laboratory Services, |
RCV001097379 | SCV001253657 | uncertain significance | SEPN1-related disorder | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV000723596 | SCV001500351 | uncertain significance | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001329142 | SCV001520478 | uncertain significance | Congenital myopathy with fiber type disproportion | 2019-12-13 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Mayo Clinic Laboratories, |
RCV000723596 | SCV002541941 | uncertain significance | not provided | 2021-11-12 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003398681 | SCV004122969 | uncertain significance | not specified | 2023-10-16 | criteria provided, single submitter | clinical testing | Variant summary: SELENON c.1654G>A (p.Glu552Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00038 in 249566 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SELENON causing Eichsfeld Type Congenital Muscular Dystrophy (0.00038 vs 0.0011), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.1654G>A in individuals affected with Eichsfeld Type Congenital Muscular Dystrophy and no experimental evidence demonstrating its impact on protein function have been reported. Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified as VUS (n=2) and benign/likely benign (n=2). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Revvity Omics, |
RCV000542565 | SCV004237870 | likely benign | Eichsfeld type congenital muscular dystrophy | 2022-05-23 | criteria provided, single submitter | clinical testing |